OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anticancer effect of novel luteolin capped gold nanoparticles selectively cytotoxic towards human cervical adenocarcinoma HeLa cells: An in vitro approach
Ivana Z. Matić, Ana Mraković, Z. Rakočević, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 80, pp. 127286-127286
Closed Access | Times Cited: 7
Ivana Z. Matić, Ana Mraković, Z. Rakočević, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 80, pp. 127286-127286
Closed Access | Times Cited: 7
Showing 7 citing articles:
Comparative Metabolomics Analysis of Terpenoid and Flavonoid in Roots of Red Beet and Sugar Beet (Beta vulgaris L.)
Wentao He, Naixin Liu, Qin Zhou, et al.
Sugar Tech (2025)
Closed Access
Wentao He, Naixin Liu, Qin Zhou, et al.
Sugar Tech (2025)
Closed Access
Harnessing Luteolin's therapeutic potential in human disorders: Medicinal significance, biological, clinical properties and analytical aspects
Abhishek Singh, Seema Yadav, Prateek Pathak, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100401-100401
Open Access | Times Cited: 4
Abhishek Singh, Seema Yadav, Prateek Pathak, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100401-100401
Open Access | Times Cited: 4
Improved anti-cancer effects of luteolin@ZIF-8 in cervical and prostate cancer cell lines
Ding Linlin, Hao Chen, Guoli Bi, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28232-e28232
Open Access | Times Cited: 4
Ding Linlin, Hao Chen, Guoli Bi, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28232-e28232
Open Access | Times Cited: 4
TCM targets ferroptosis: potential treatments for cancer
Liwen Qin, Yuhan Zhong, Yi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Liwen Qin, Yuhan Zhong, Yi Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Novel Strategies for Tumor Treatment: Harnessing ROS-Inducing Active Ingredients from Traditional Chinese Medicine Through Multifunctional Nanoformulations
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 1
Zhengguang Zhang, M. Y. Li, Xiaolong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9659-9688
Open Access | Times Cited: 1
The Recent Development of Luteolin-loaded Nanocarrier in Targeting Cancer
Biswakanth Kar, Sudhanshu Ranjan Rout, Jitu Halder, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 27, pp. 2129-2141
Open Access
Biswakanth Kar, Sudhanshu Ranjan Rout, Jitu Halder, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 27, pp. 2129-2141
Open Access
Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action
Wamidh H. Talib, Media Mohammed Baban, Mais Fuad Bulbul, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9593-9593
Open Access
Wamidh H. Talib, Media Mohammed Baban, Mais Fuad Bulbul, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9593-9593
Open Access
